IDDI at 2nd Ophthalmic Drug Development Summit
July 25, 2017 — July 27, 2017
IDDI at the 2nd Ophthalmic Drug Development Summit in Boston. Want to accelerate the development of your ocular drug? Meet IDDI there:
- Vicky Martin our Director BD US and contact her at email@example.com
The growing disease burden and emergence of innovative new therapeutics means that the multi-billion dollar ophthalmic drug market is poised for near double digit compound growth over the next 5 years. There is enormous untapped potential for companies focusing on developing novel approaches to tackle age related macular degeneration, diabetic macular edema, glaucoma and other degenerative ocular conditions.
Focussing specifically on the challenges drug developers face in the development and delivery of clinically effective ocular drugs, the 2nd Annual Ophthalmic Drug Development Summit is your opportunity to fast-track your development efforts in this space.